Oaktree Acquisition III Life Sciences Q2 FY26 net income drops to $1.6 million

• Oaktree Acquisition III Life Sciences posted net income of USD 1.6 million for the three months ended June 30, 2026.
• Earnings fell 14.38% year over year on interest income of USD 1.87 million, offset by general and administrative costs of 261,958.
• Six-month net income slipped 15.12% to USD 3 million, reflecting interest income of USD 3.72 million.
• General and administrative expenses totaled 718,496 for the six-month period, while operating cash outflow was 255,295.
• Cash held in the trust account was USD 205.28 million at June 30, 2026, with USD 1.18 million held outside the trust.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oaktree Acquisition III Life Sciences Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-346973), on August 12, 2026, and is solely responsible for the information contained therein.